Brentwood-based pathology services provider PathGroup announced today that it has opened two new state-of-the-art facilities dedicated exclusively to molecular and cytology testing.
The new laboratories, the price tags for which were not disclosed in a release, are located adjacent to PathGroup’s current laboratory at 658 Grassmere Park in South Nashville. The facilities will allow specialists to perform molecular assays for oncology, including next-generation sequencing, as well as infectious disease and women’s health diagnostics. The new space also includes a clinical laboratory improvement amendments (CLIA)-validation laboratory for test development and implementation.
PathGroup will continue to operate from its existing 40,000-square-foot laboratory. With the new labs adding approximately 20,000 square feet of space, PathGroup now has more than 85,000 square feet of space of operational and corporate headquarters space.
“As a leading pathology services provider, we continue to advance the organization to meet the needs of the evolving healthcare landscape,” Dr. Ben Davis (pictured), PathGroup chairman, president and CEO, said in the release. “We felt it was imperative that we commit space and resources that will enable PathGroup to stay at the forefront of advances in laboratory medicine. We will continue to provide high quality care and adapt to the ever changing healthcare industry.”